These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8250731)
1. [Serum levels of soluble CD25 (soluble interleukin 2 receptor) in asthmatic patients]. Shiota Y; Sato T; Ono T Arerugi; 1993 Aug; 42(8):914-9. PubMed ID: 8250731 [TBL] [Abstract][Full Text] [Related]
2. [Serum soluble CD23 and soluble CD25 in bronchial asthmatic patients]. Shiota Y; Sato T; Ono T; Kaji M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Aug; 31(8):932-5. PubMed ID: 8230890 [TBL] [Abstract][Full Text] [Related]
3. [Serum levels of soluble ICAM-1 in asthmatic patients]. Shiota Y; Sato T; Ono T Arerugi; 1993 Dec; 42(12):1782-7. PubMed ID: 7906509 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor in sputum from patients with bronchial asthma. Motojima S; Ogata H; Tateishi K; Kushima A; Yamai T; Fukuda T; Makino S Arerugi; 1993 Feb; 42(2):162-6. PubMed ID: 8507158 [TBL] [Abstract][Full Text] [Related]
5. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. Bogner MP; Voss SD; Bechhofer R; Hank JA; Roper M; Poplack D; Hammond D; Sondel PM J Immunother (1991); 1992 Feb; 11(2):111-8. PubMed ID: 1571333 [TBL] [Abstract][Full Text] [Related]
6. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma]. Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831 [TBL] [Abstract][Full Text] [Related]
7. [Proliferation of T lymphocyte subsets in asthma patients in clinical remission and molecular mechanism thereof]. Feng MJ; Qiu C; Chen CX; Li FR Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1594-8. PubMed ID: 17803846 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis. Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340 [TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptors in patients with Bell's palsy. Bujía J; Kim C; Bruegel F Allergol Immunopathol (Madr); 1996; 24(3):112-5. PubMed ID: 8766741 [TBL] [Abstract][Full Text] [Related]
10. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission. Pumputiene I; Emuzyte R; Dubakiene R; Firantiene R; Tamosiunas V Allergy; 2006 Jan; 61(1):43-8. PubMed ID: 16364155 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls. Hoeger PH; Niggemann B; Ganschow R; Dammann C; Haeuser G Allergy; 1994 Apr; 49(4):217-21. PubMed ID: 8037354 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078 [TBL] [Abstract][Full Text] [Related]
13. Steroid-resistant asthma immunologic characteristics. Sun Y; Luo W Chin Med J (Engl); 1996 Jul; 109(7):527-32. PubMed ID: 9206099 [TBL] [Abstract][Full Text] [Related]
14. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection]. Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma. Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323 [TBL] [Abstract][Full Text] [Related]
16. Soluble CD86 protein in serum samples of patients with asthma. Shi HZ; Xie ZF; Deng JM; Chen YQ; Xiao CQ Thorax; 2004 Oct; 59(10):870-5. PubMed ID: 15454653 [TBL] [Abstract][Full Text] [Related]
17. Soluble serum interleukin 2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis. Brown JE; Greenberger PA; Yarnold PR Ann Allergy Asthma Immunol; 1995 Jun; 74(6):484-8. PubMed ID: 7788514 [TBL] [Abstract][Full Text] [Related]
18. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Hol BE; Hintzen RQ; Van Lier RA; Alberts C; Out TA; Jansen HM Am Rev Respir Dis; 1993 Sep; 148(3):643-9. PubMed ID: 8396372 [TBL] [Abstract][Full Text] [Related]
19. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
20. [Imbalanced T cell-specific transcription factors T-bet and GATA-3 contributes to type 2 T helper cell polarization in asthmatic patients]. Liu CT; Wang G; Luo FM; Wang ZL; Liu R; Wang CL Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):398-402. PubMed ID: 15256090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]